Open AccessHIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial
Author(s) -
Elizabeth M. Stringer,
Jens Levy,
Moses Sinkala,
H. Benjamin,
Inutu Matongo,
Namwinga Chintu,
Jeffrey S. A. Stringer
Publication year - 2009
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32832cbca8
Subject(s) - medicine , hazard ratio , pill , hormonal contraception , intrauterine device , gynecology , family planning , obstetrics , randomized controlled trial , confidence interval , medroxyprogesterone acetate , population , hormone , research methodology , environmental health , pharmacology
HIV-infected women need access to safe contraception. We hypothesized that women using depomedroxyprogesterone acetate (DMPA) contraception would have faster HIV disease progression than women using oral contraceptive pills (OCPs) and nonhormonal methods.